Sharholder Information

2023 Shareholders' Meeting

2023 Annual Shareholders' Meeting
Time: 9:30 AM, June 1 (Thursday), 2023
Venue: 2F, No.19-10, Sanchong Rd., Nankang Dist., Taipei City 115, Taiwan (R.O.C.)
(The International Conference Center, 2nd Floor, Building A, Nankang Software Park)

 Annual Report      


Major Shareholders

Names, number of shares and shareholding percentage of the shareholders whose shareholding percentage was more than 5% of the total shares or the shareholders with top 10 shareholding percentage:

                                                                                          April 3, 2023; Unit:Shares

Major Shareholder’s name Number of Shares Held Shareholding Percentage (%)
 Foresee Pharmaceuticals, Inc. 23,710,357 20.05%
 Hsu Xiu Mei 5,385,000 4.55%
 Zheng Jun Zhong 3,389,000 2.87%
 Larry Chuanming Duan 2,092,316 1.77%
 Huang Rui Xing 1,760,000 1.49%
 Lee Yi Shung 1,502,821 1.27%
 Lee Der Shung 1,502,821 1.27%
Investment Account of Kumar Ramu, with Yuanta Commercial Bank as the custodian trustee 1,418,370 1.20%
JPMorgan Chase Bank N.A., Taipei Branch in custody for Vanguard Total International Stock Index Fund, a series of Vanguard Star Funds 1,080,000 0.91%
 Zhang Yong Zheng 1,021,000 0.86%


Investor Contacts

Kana Huang
Investor Relations | Public Relations

[email protected]

Which stock exchanges are Foresee traded on and what is the stock code?

Foreseepharma shares were listed on the Taipei Exchange on June 29, 2018, under Taipei Exchange code "6576".

Where can I find historical financial information on Foresee?

You can find this information in the Financial Information section.

What is Foresee's official accounting currency?

Foresee reports in New Taiwanese Dollars.

Whom do I contact for stock affairs?

If you have a custodian bank account in Taiwan, please contact them directly. If you do not have a bank account and securities account in Taiwan, please contact: [email protected]

Where can I find dividend information?

Foresee currently does not have a dividend or a dividend reinvestment plan.